Skip to main content

Table 1 The demographic and clinical characteristics of patients with PCOS and CON

From: Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome

 

CON

PCOS

P

Age, years

30.38 ± 3.02

27.13 ± 5.74

0.178

BMI, kg/m2

20.85 ± 1.79

22.42 ± 2.95

0.219

Basal FSH,mIU/mL

6.78 ± 1.35

6.1 ± 1.26

0.311

Basal LH,mIU/mL

5.92 ± 3.33

13.35 ± 6.9

0.016

LH/FSH

0.88 ± 0.46

2.19 ± 1.0

0.008

Basal E2,nmol/L

47.88 ± 29.39

51.88 ± 31.14

0.795

AMH, ng/mL

5.46 ± 1.65

11.02 ± 4.48

0.009

TT, nmol/L

40.4 ± 10.61

76.92 ± 29.66

0.01

No. of oocytes retrieved

13.13 ± 6.85

18.75 ± 5.85

0.099

No. of MII oocyte

10.63 ± 6.91

16 ± 5.55

0.108

Nuclear maturation (MII) rate

0.76 ± 0.16

0.86 ± 0.17

0.242

2PN

8.75 ± 5.92

13.38 ± 5.95

0.142

2PN Fertilization rate

0.84 ± 0.2

0.83 ± 0.16

0.869

Number of frozen embryos

2.43 ± 0.79

2.33 ± 0.82

0.837

Number of blastocysts

5.4 ± 5.13

5.88 ± 4.88

0.814

Frozen embryo rate

0.59 ± 0.39

0.32 ± 0.23

0.077

Blastocyst rate

0.41 ± 0.39

0.68 ± 0.23

0.077

High-quality embryo

5.5 ± 3.89

7.63 ± 3.81

0.289

High-quality embryo rate

0.7 ± 0.24

0.59 ± 0.19

0.342

Pregnancy rate

0.625

0.75

0.000

  1. Data are presented as mean ± SD. a Compared with the CON group. BMI body mass index; bFSH basic follicle-stimulating hormone, bLH basic luteinizing hormone; bE2 basic estrogen, AMH Anti-Mullerian hormone; TT total testosterone, MII metaphase II.Comparison was done by unpaired t test. P < 0.05 is statistically significant
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us